BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ortho Biotech Products, L.P. 

P.O. Box 6914
430 Rt. 22 East
Bridgewater  New Jersey  08807-0914  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology






 Company News
Ortho Biotech Products, L.P. Study Finds DOXIL(R) Combination Therapy Delays Disease Progression for Patients With Metastatic Breast Cancer 12/15/2008 6:33:36 AM    More...
Ortho Biotech Products, L.P. Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer 11/20/2008 8:01:05 AM    More...
Ortho Biotech Products, L.P. Release: Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting 11/7/2008 11:26:06 AM    More...
Ortho Biotech Products, L.P. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa 9/18/2008 10:28:51 AM    More...
Ortho Biotech Products, L.P. Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer 9/8/2008 7:35:04 AM    More...
Janssen-Cilag International NV (JNJ), Ortho Biotech Products, L.P. VELCADE(R) Approved For Previously Untreated Multiple Myeloma 9/8/2008 7:00:14 AM    More...
Ortho Biotech Products, L.P. Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A 8/5/2008 5:54:41 PM    More...
Ortho Biotech Products, L.P. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology Annual Meeting 5/30/2008 11:09:23 AM    More...
Ortho Biotech Products, L.P. and Centocor, Inc. (JNJ) Alert Authorized Distributors and Prescribing Physicians About Stolen Product 5/15/2008 2:04:26 PM    More...
Ortho Biotech Products, L.P. Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets 4/11/2008 10:13:49 AM    More...
1234567

//-->